About BRI Biopharmaceutical Research
BRI Biopharmaceutical Research is a company based in Vancouver (Canada) founded in 1991 was acquired by Frontage Laboratories in December 2019.. BRI Biopharmaceutical Research operates in a competitive market with competitors including BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others.
- Headquarter Vancouver, Canada
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Frontage Laboratories
(Dec 16, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BRI Biopharmaceutical Research
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BRI Biopharmaceutical Research
BRI Biopharmaceutical Research has secured backing from 1 investor. Prominent investors backing the company include Frontage Laboratories. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early drug development services are provided for pharma firms.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BRI Biopharmaceutical Research
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BRI Biopharmaceutical Research
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bri Biopharmaceutical Research Comparisons
Competitors of BRI Biopharmaceutical Research
BRI Biopharmaceutical Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Advion, Tentamus, Nordic Bioscience and Alderley Analytical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
|
| domain | founded_year | HQ Location |
Microfluidics and mass spectrometry products are provided for clinical research.
|
|
| domain | founded_year | HQ Location |
Analytical and quality assurance services are provided for diverse industries.
|
|
| domain | founded_year | HQ Location |
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
|
|
| domain | founded_year | HQ Location |
Bioanalytical assays for drug development are developed and validated.
|
|
| domain | founded_year | HQ Location |
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bri Biopharmaceutical Research
Frequently Asked Questions about BRI Biopharmaceutical Research
When was BRI Biopharmaceutical Research founded?
BRI Biopharmaceutical Research was founded in 1991.
Where is BRI Biopharmaceutical Research located?
BRI Biopharmaceutical Research is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
What does BRI Biopharmaceutical Research do?
Biopharmaceutical Research Inc (BRI) is a CRO offering analytical and bioanalytical services for all stages of drug development. The companys service portfolio includes Bioanalytical Assays for Clinical Trials, in-vivo and in-vitro early drug candidate screening, DMPK and ADME studies, Tumor-Derived Xenograft Models for Drug Development and Personalized Drug Sensitivity Evaluation , CMC development services including drug substance and drug product stability studies. The companys trademark technologies are Oncograph, a patient-derived Xenograft efficacy mouse model and BRIVAL, a high-throughput in vitro cytochrome CYP450 assay which can be used for screening preclinical drug candidates. BRI is accredited by AAALAC and CCAC (Canadian Council on Animal Care).
Who are the top competitors of BRI Biopharmaceutical Research?
BRI Biopharmaceutical Research's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.
Who are BRI Biopharmaceutical Research's investors?
BRI Biopharmaceutical Research has 1 investor. Key investors include Frontage Laboratories.